Abbott Laboratories (ABT) Q4 2023 Earnings Results

Abbott Labs Meets EPS Expectations, Stock Down 2.83%

Abbott Labs reported earnings that met expectations for EPS, but the stock fell by 2.83% following the announcement. The decline may reflect investor concerns about market challenges and the lack of new guidance. Overall, the company seems to be maintaining stability, but uncertainty remains in certain areas.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.19	N/A	+0.00%

Management

Management commentary

Tone: Neutral

Overall, management expressed a steady outlook but acknowledged some market pressures. There was no significant change in their strategic direction.

Management highlighted stability in core product lines.

They noted ongoing challenges in certain market segments.

Abbott Labs Meets EPS Expectations, Stock Down 2.83%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Meets EPS Expectations, Stock Down 2.83%

Key numbers

Management commentary